Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 72 points (-0.5%) at 15,564 as of Friday, Sept. 20, 2013, 12:54 PM ET. The NYSE advances/declines ratio sits at 854 issues advancing vs. 2,087 declining with 92 unchanged. The Health Services industry currently sits up 0.4% versus the S&P 500, which is down 0.4%. Top gainers within the industry include Agilent Technologies ( A), up 1.8%, Grifols ( GRFS), up 1.3%, Cigna ( CI), up 1.2% and UnitedHealth Group ( UNH), up 0.7%. On the negative front, top decliners within the industry include Insulet Corporation ( PODD), down 5.3%, Catamaran ( CTRX), down 3.5%, Brookdale Senior Living ( BKD), down 2.2% and HCA Holdings ( HCA), down 1.1%. TheStreet would like to highlight 5 stocks pushing the industry higher today: 5. Techne Corporation ( TECH) is one of the companies pushing the Health Services industry higher today. As of noon trading, Techne Corporation is up $4.18 (5.4%) to $81.90 on heavy volume. Thus far, 224,118 shares of Techne Corporation exchanged hands as compared to its average daily volume of 121,100 shares. The stock has ranged in price between $80.09-$83.83 after having opened the day at $80.33 as compared to the previous trading day's close of $77.72. Techne Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls worldwide. It operates in two segments, Biotechnology and Clinical Controls. Techne Corporation has a market cap of $2.8 billion and is part of the health care sector. Shares are up 12.7% year to date as of the close of trading on Thursday. Currently there is 1 analyst that rates Techne Corporation a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates Techne Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Techne Corporation Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.